BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Petru Manescu

Petru Manescu contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
Computer VisionMachine Learning

Trust snapshot

Quick read

Trust 17 - Baseline
4works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2026arXiv

HemBLIP: A Vision-Language Model for Interpretable Leukemia Cell Morphology Analysis

Microscopic evaluation of white blood cell morphology is central to leukemia diagnosis, yet current deep learning models often act as black boxes, limiting clinical trust and adoption. We introduce HemBLIP, a vision language model designed to generate interpretable, morphology aware descriptions of peripheral blood cells. Using a newly constructed dataset of 14k healthy and leukemic cells paired with expert-derived attribute captions, we adapt a general-purpose VLM via both full fine-tuning and LoRA based parameter efficient training, and benchmark against the biomedical foundation model MedGEMMA. HemBLIP achieves higher caption quality and morphological accuracy, while LoRA adaptation provides further gains with significantly reduced computational cost. These results highlight the promise of vision language models for transparent and scalable hematological diagnostics.

0 citations0 reviewsNo code linkedOpen access
preprint2026arXiv

LesionTABE: Equitable AI for Skin Lesion Detection

Bias remains a major barrier to the clinical adoption of AI in dermatology, as diagnostic models underperform on darker skin tones. We present LesionTABE, a fairness-centric framework that couples adversarial debiasing with dermatology-specific foundation model embeddings. Evaluated across multiple datasets covering both malignant and inflammatory conditions, LesionTABE achieves over a 25\% improvement in fairness metrics compared to a ResNet-152 baseline, outperforming existing debiasing methods while simultaneously enhancing overall diagnostic accuracy. These results highlight the potential of foundation model debiasing as a step towards equitable clinical AI adoption.

0 citations0 reviewsNo code linkedOpen access
preprint2026arXiv

MORPHFED: Federated Learning for Cross-institutional Blood Morphology Analysis

Automated blood morphology analysis can support hematological diagnostics in low- and middle-income countries (LMICs) but remains sensitive to dataset shifts from staining variability, imaging differences, and rare morphologies. Building centralized datasets to capture this diversity is often infeasible due to privacy regulations and data-sharing restrictions. We introduce a federated learning framework for white blood cell morphology analysis that enables collaborative training across institutions without exchanging training data. Using blood films from multiple clinical sites, our federated models learn robust, domain-invariant representations while preserving complete data privacy. Evaluations across convolutional and transformer-based architectures show that federated training achieves strong cross-site performance and improved generalization to unseen institutions compared to centralized training. These findings highlight federated learning as a practical and privacy-preserving approach for developing equitable, scalable, and generalizable medical imaging AI in resource-limited healthcare environments.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Automated Detection of Acute Promyelocytic Leukemia in Blood Films and Bone Marrow Aspirates with Annotation-free Deep Learning

While optical microscopy inspection of blood films and bone marrow aspirates by a hematologist is a crucial step in establishing diagnosis of acute leukemia, especially in low-resource settings where other diagnostic modalities might not be available, the task remains time-consuming and prone to human inconsistencies. This has an impact especially in cases of Acute Promyelocytic Leukemia (APL) that require urgent treatment. Integration of automated computational hematopathology into clinical workflows can improve the throughput of these services and reduce cognitive human error. However, a major bottleneck in deploying such systems is a lack of sufficient cell morphological object-labels annotations to train deep learning models. We overcome this by leveraging patient diagnostic labels to train weakly-supervised models that detect different types of acute leukemia. We introduce a deep learning approach, Multiple Instance Learning for Leukocyte Identification (MILLIE), able to perform automated reliable analysis of blood films with minimal supervision. Without being trained to classify individual cells, MILLIE differentiates between acute lymphoblastic and myeloblastic leukemia in blood films. More importantly, MILLIE detects APL in blood films (AUC 0.94+/-0.04) and in bone marrow aspirates (AUC 0.99+/-0.01). MILLIE is a viable solution to augment the throughput of clinical pathways that require assessment of blood film microscopy.

0 citations0 reviewsNo code linkedOpen access